1-4 of 4
Brian Kavanagh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2728: Thermal ablative therapy with novel gold nanorods in an orthotopic model of urinary bladder cancer

Free
Xiaoping Yang, Lih-Jen Su, Francisco G. La Rosa, Elizabeth Erin Smith, Suehyun Katherine Cho, Brian Kavanagh, Won Park, Thomas W. Flaig
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2728.
https://doi.org/10.1158/1538-7445.AM2014-2728
Published: 01 October 2014
View article titled, Abstract 2728: Thermal ablative therapy with novel gold nanorods in an orthotopic model of urinary bladder cancer
Journal Articles

Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF

Free
Lawrence Fong, Serena S. Kwek, Shaun O'Brien, Brian Kavanagh, Douglas G. McNeel, Vivian Weinberg, Amy M. Lin, Jonathan Rosenberg, Charles J. Ryan, Brian I. Rini, Eric J. Small
Journal: Cancer Research
Cancer Res (2009) 69 (2): 609–615.
https://doi.org/10.1158/0008-5472.CAN-08-3529
Published: 15 January 2009
View article titled, Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF
Open the PDF for Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF in another window
Journal Articles

Abstract 2539: CTLA-4 blockade for hormone refractory prostate cancer: Dose-dependent induction of CD8+ T cell activation and clinical responses

Free
Lawrence Fong, Serena Kwek, Brian Kavanagh, Shaun O'Brien, Douglas McNeel, Vivian Weinberg, Brian Rini, Eric J. Small
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 2539.
https://doi.org/10.1158/1538-7445.AM2008-2539
Published: 15 May 2008
View article titled, Abstract 2539: CTLA-4 blockade for hormone refractory prostate cancer: Dose-dependent induction of CD8+ T cell activation and clinical responses
Journal Articles

CTLA-4 blockade for hormone refractory prostate cancer: Dose-dependent induction of CD8+ T cell activation and clinical responses

Free
Lawrence Fong, Serena Kwek, Brian Kavanagh, Shaun O'Brien, Douglas McNeel, Vivian Weinberg, Brian Rini, Eric Small
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 2539.
Published: 01 May 2008
View article titled, CTLA-4 blockade for hormone refractory prostate cancer: Dose-dependent induction of CD8+ T cell activation and clinical responses